5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne diseaseRecruitingPhase 22026-09-10NCT07811908
Dose Finding Trial of R21/Matrix-M in School ChildrenInfections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne diseaseActive, not recruitingPhase 22026-08-24NCT07074665
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-MInfections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne diseaseActive, not recruitingPhase 22026-03-11NCT07183371
Safety of Antimalarials in the FIRst trimEsterInfections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne diseaseRecruitingPhase 32025-11-19NCT06962319
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaInfections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne diseaseRecruitingPhase 22025-07-30NCT05750628